Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor
Stethoscope, money and medical bills

Life Health > Health Insurance > Medicare Planning

Advisors, Medicare and the Election: Reading Between the Headlines

X
Your article was successfully shared with the contacts you provided.

What You Need to Know

  • Retiree health care expenses are still rising even as presidential candidates and voters have shifted attention elsewhere.
  • Biden's efforts to control drug costs have gotten positive press, but the reality is more nuanced.
  • Medigap plans have been shifting rising costs to consumers for years.

Normally in an election year, the future of Medicare would be among the top concerns of voters.

This is shaping up to be no ordinary year, with wars in Europe and the Middle East, and legal battles in courtrooms across the country dominating headlines.

A lot can (and will) happen between now and Nov. 5 that could bring competing visions of Medicare to the top of candidates’ and voters’ priorities.

But for many candidates, the fear of touching a third-rail issue will crowd out any meaningful discussion of this critical program.

That does not mean that Medicare will not be on the ballot or that advisors should not be paying close attention to what comes next.

Clients continue to ask basic questions:

Will I be able to count on Medicare and Social Security in retirement?

Should I plan on receiving reduced benefits?

The Quiet Squeeze

As we detailed in our recent Medicare Part D National Data Report, while provisions in the Inflation Reduction Act will lower drug-related out-of-pocket (OOP) expenses for some and likely slow the rate of increase of these costs, average premiums across three of the largest national carriers surged in 2024 by 16% to 53% across all 50 states.

By lowering the catastrophic cap from $8,000 this year to $2,000 in 2025, the financial exposure for the 25% of Americans who currently exceed the lower limit in drug-related OOP costs may be significantly reduced.

However, many of the 25% will actually pay more in combined premiums and OOPs for Part D coverage based on medications and how far their costs are above the $2,000 maximum, and all will pay higher premiums.

This underscores a basic reality when it comes to health care costs: When you squeeze the toothpaste tube at one end, it comes out somewhere else.

Although higher premiums will for many be a price worth paying, it’s not a political talking point.

The Real Costs

With the attention that has been given to steps the Biden administration has taken to tackle rising drug-related out-of-pocket costs, which also include negotiating drug prices for the first time, it should be no surprise that there is a palpable sense that retirement health care expenses will be lower in the future.

The reality is far more nuanced.

The changes are likely to reduce the rate of increase in out-of-pocket costs — a significant benefit — but if we look at all components of retirement health care costs (Parts B and D premiums, supplemental insurance, other out-of-pocket expenses), our actuarial data projects a steady overall increase in costs, consistent with the long-term trend of 1.5 to 2 times the consumer price index (CPI).

Hopefully the rate of increase going forward will be lower than the historical trend.

But since costs will rise over time, driven by health care inflation, age ratings of supplemental insurance, and increased utilization of services, these factors should be considered as part of the planning process.

Our data show a healthy 65-year-old couple starting retirement on Jan. 1 this year should plan to cover $16,113 in actuarially calculated annual health care costs in 2024 and $50,724 at age 87.

Medicare Part D premiums are a microcosm of the bigger overall Medicare and retirement health care picture in which optimism tends to get ahead of reality.

The cost of the Medicare program accounted for 3.7% of GDP in 2022, according to the most recent trust fund report.

By 2047, that number is expected to be 6.0%, driven by the rising cost of care and the demographic tidal wave of retiring baby boomers.

Looking at the average per beneficiary cost of Medicare to the government, The New York Times reported in 2023 that costs were flat on a per person basis over the last decade.

The data failed to account for the fact that the population of Medicare recipients skewed significantly younger and healthier as boomers retired.

The demographic reality is that overall costs to the government increased by 73% over this time period.

And, as boomers age, the per beneficiary cost will also rise as retirees age and need more care.

The Case of Medigap

Unsurprisingly, 2024 presidential candidates have barely discussed how to maintain Medicare’s long-term solvency, which most likely will include rising premiums, changes to Social Security’s full retirement age, or increased taxes on the wealthy.

Higher Part B and D premiums should be a reality check for advisors and clients.

This year’s jump in Part D premiums, which may well be repeated in advance of 2025, highlights another truism — as costs are shifted to the private sector, they will be passed along to retirees.

This cost shifting, both in the form of higher premiums or lower benefits for the same cost, has been going on for years with Medicare supplement insurance, or Medigap coverage, a case in point.

As an example, in 2020, Medigap Plan F — which provided the greatest level of coverage for Medicare recipients — was eliminated for new enrollees, leaving them with higher out-of-pocket liabilities on other available plans.

The hard truth of retirement health care is that advisors and clients should be planning for higher, not lower costs.

Inflation Reduction Act provisions will likely bend the annual health care inflation rate curve but not change its upward trajectory.

Armed with data that considers all the components of health-related expenses in retirement, advisors have a key role to work with clients to set realistic expectations for future costs, and help clients plan for them.


Ron Mastrogiovanni (Photo: HealthView)Ron Mastrogiovanni is the CEO of HealthView Services, a provider of retirement, health care, Social Security, long-term care applications, retirement planning and decumulation tools for the financial services industry.

..

..

Credit: Yavor Momchilov Uzunov/Wikimedia Commons


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.